Thrombin inhibitors built on an azaphenylalanine scaffold

A series of azaphenylalanine derivatives were investigated as novel thrombin inhibitors based on the prodrug principle. By systematic structural modifications we have identified optimal groups for this series that led us to potent inhibitors of thrombin incorporating the benzamidine fragment at the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2004-03, Vol.14 (6), p.1563-1567
Hauptverfasser: Zega, Anamarija, Mlinšek, Gregor, Šolmajer, Tomaž, Trampuš-Bakija, Alenka, Stegnar, Mojca, Urleb, Uroš
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1567
container_issue 6
container_start_page 1563
container_title Bioorganic & medicinal chemistry letters
container_volume 14
creator Zega, Anamarija
Mlinšek, Gregor
Šolmajer, Tomaž
Trampuš-Bakija, Alenka
Stegnar, Mojca
Urleb, Uroš
description A series of azaphenylalanine derivatives were investigated as novel thrombin inhibitors based on the prodrug principle. By systematic structural modifications we have identified optimal groups for this series that led us to potent inhibitors of thrombin incorporating the benzamidine fragment at the P1 position, and their potentially orally active benzamidoxime prodrugs. The binding modes in the thrombin active site of two representative compounds were identified by X-ray crystallographic analysis. Graphic
doi_str_mv 10.1016/j.bmcl.2003.12.083
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71716507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X04000095</els_id><sourcerecordid>71716507</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-df481de899bc7dcda208af6e57fe9c74236377dca1fa846c2c0e9cdbfc3158f03</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOo6-gAvpRnetJ02apuBGBm8w4GYEdyHNhcnQy5i0wvj0psyAroTACTnf-Tn5ELrCkGHA7G6T1a1qshyAZDjPgJMjNMOU0ZRQKI7RDCoGKa_oxxk6D2EDgClQeorOcAHA4n2GqtXa923tusR1a1e7ofchqUfXDEnfJTKeb7ldm27XyEZ2rjNJUNLavtEX6MTKJpjLQ52j96fH1eIlXb49vy4elqkiPB9SbSnH2vCqqlWplZY5cGmZKUprKlXSnDBSxobEVnLKVK4gvuvaKoILboHM0e0-d-v7z9GEQbQuKNPEdUw_BlHiErMCygjme1D5PgRvrNh610q_ExjEJExsxCRMTMIEzkUUFoeuD-lj3Rr9O3IwFIGbAyDjzxvrZadc-MOxgvByCrrfcya6-HLGi6Cc6ZTRzhs1CN27__b4AUuKifQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71716507</pqid></control><display><type>article</type><title>Thrombin inhibitors built on an azaphenylalanine scaffold</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zega, Anamarija ; Mlinšek, Gregor ; Šolmajer, Tomaž ; Trampuš-Bakija, Alenka ; Stegnar, Mojca ; Urleb, Uroš</creator><creatorcontrib>Zega, Anamarija ; Mlinšek, Gregor ; Šolmajer, Tomaž ; Trampuš-Bakija, Alenka ; Stegnar, Mojca ; Urleb, Uroš</creatorcontrib><description>A series of azaphenylalanine derivatives were investigated as novel thrombin inhibitors based on the prodrug principle. By systematic structural modifications we have identified optimal groups for this series that led us to potent inhibitors of thrombin incorporating the benzamidine fragment at the P1 position, and their potentially orally active benzamidoxime prodrugs. The binding modes in the thrombin active site of two representative compounds were identified by X-ray crystallographic analysis. Graphic</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2003.12.083</identifier><identifier>PMID: 15006404</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Aza Compounds - chemistry ; Aza Compounds - metabolism ; Azapeptidomimetics ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Medical sciences ; Pharmacology. Drug treatments ; Phenylalanine - chemistry ; Phenylalanine - metabolism ; Prodrug ; Protein Binding ; Serine Proteinase Inhibitors - chemical synthesis ; Serine Proteinase Inhibitors - metabolism ; Thrombin - antagonists &amp; inhibitors ; Thrombin - metabolism ; Thrombin inhibitors</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2004-03, Vol.14 (6), p.1563-1567</ispartof><rights>2004</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-df481de899bc7dcda208af6e57fe9c74236377dca1fa846c2c0e9cdbfc3158f03</citedby><cites>FETCH-LOGICAL-c382t-df481de899bc7dcda208af6e57fe9c74236377dca1fa846c2c0e9cdbfc3158f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X04000095$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15653873$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15006404$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zega, Anamarija</creatorcontrib><creatorcontrib>Mlinšek, Gregor</creatorcontrib><creatorcontrib>Šolmajer, Tomaž</creatorcontrib><creatorcontrib>Trampuš-Bakija, Alenka</creatorcontrib><creatorcontrib>Stegnar, Mojca</creatorcontrib><creatorcontrib>Urleb, Uroš</creatorcontrib><title>Thrombin inhibitors built on an azaphenylalanine scaffold</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A series of azaphenylalanine derivatives were investigated as novel thrombin inhibitors based on the prodrug principle. By systematic structural modifications we have identified optimal groups for this series that led us to potent inhibitors of thrombin incorporating the benzamidine fragment at the P1 position, and their potentially orally active benzamidoxime prodrugs. The binding modes in the thrombin active site of two representative compounds were identified by X-ray crystallographic analysis. Graphic</description><subject>Aza Compounds - chemistry</subject><subject>Aza Compounds - metabolism</subject><subject>Azapeptidomimetics</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenylalanine - chemistry</subject><subject>Phenylalanine - metabolism</subject><subject>Prodrug</subject><subject>Protein Binding</subject><subject>Serine Proteinase Inhibitors - chemical synthesis</subject><subject>Serine Proteinase Inhibitors - metabolism</subject><subject>Thrombin - antagonists &amp; inhibitors</subject><subject>Thrombin - metabolism</subject><subject>Thrombin inhibitors</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKxDAUhoMoOo6-gAvpRnetJ02apuBGBm8w4GYEdyHNhcnQy5i0wvj0psyAroTACTnf-Tn5ELrCkGHA7G6T1a1qshyAZDjPgJMjNMOU0ZRQKI7RDCoGKa_oxxk6D2EDgClQeorOcAHA4n2GqtXa923tusR1a1e7ofchqUfXDEnfJTKeb7ldm27XyEZ2rjNJUNLavtEX6MTKJpjLQ52j96fH1eIlXb49vy4elqkiPB9SbSnH2vCqqlWplZY5cGmZKUprKlXSnDBSxobEVnLKVK4gvuvaKoILboHM0e0-d-v7z9GEQbQuKNPEdUw_BlHiErMCygjme1D5PgRvrNh610q_ExjEJExsxCRMTMIEzkUUFoeuD-lj3Rr9O3IwFIGbAyDjzxvrZadc-MOxgvByCrrfcya6-HLGi6Cc6ZTRzhs1CN27__b4AUuKifQ</recordid><startdate>20040322</startdate><enddate>20040322</enddate><creator>Zega, Anamarija</creator><creator>Mlinšek, Gregor</creator><creator>Šolmajer, Tomaž</creator><creator>Trampuš-Bakija, Alenka</creator><creator>Stegnar, Mojca</creator><creator>Urleb, Uroš</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040322</creationdate><title>Thrombin inhibitors built on an azaphenylalanine scaffold</title><author>Zega, Anamarija ; Mlinšek, Gregor ; Šolmajer, Tomaž ; Trampuš-Bakija, Alenka ; Stegnar, Mojca ; Urleb, Uroš</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-df481de899bc7dcda208af6e57fe9c74236377dca1fa846c2c0e9cdbfc3158f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aza Compounds - chemistry</topic><topic>Aza Compounds - metabolism</topic><topic>Azapeptidomimetics</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenylalanine - chemistry</topic><topic>Phenylalanine - metabolism</topic><topic>Prodrug</topic><topic>Protein Binding</topic><topic>Serine Proteinase Inhibitors - chemical synthesis</topic><topic>Serine Proteinase Inhibitors - metabolism</topic><topic>Thrombin - antagonists &amp; inhibitors</topic><topic>Thrombin - metabolism</topic><topic>Thrombin inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zega, Anamarija</creatorcontrib><creatorcontrib>Mlinšek, Gregor</creatorcontrib><creatorcontrib>Šolmajer, Tomaž</creatorcontrib><creatorcontrib>Trampuš-Bakija, Alenka</creatorcontrib><creatorcontrib>Stegnar, Mojca</creatorcontrib><creatorcontrib>Urleb, Uroš</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zega, Anamarija</au><au>Mlinšek, Gregor</au><au>Šolmajer, Tomaž</au><au>Trampuš-Bakija, Alenka</au><au>Stegnar, Mojca</au><au>Urleb, Uroš</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thrombin inhibitors built on an azaphenylalanine scaffold</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2004-03-22</date><risdate>2004</risdate><volume>14</volume><issue>6</issue><spage>1563</spage><epage>1567</epage><pages>1563-1567</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A series of azaphenylalanine derivatives were investigated as novel thrombin inhibitors based on the prodrug principle. By systematic structural modifications we have identified optimal groups for this series that led us to potent inhibitors of thrombin incorporating the benzamidine fragment at the P1 position, and their potentially orally active benzamidoxime prodrugs. The binding modes in the thrombin active site of two representative compounds were identified by X-ray crystallographic analysis. Graphic</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>15006404</pmid><doi>10.1016/j.bmcl.2003.12.083</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2004-03, Vol.14 (6), p.1563-1567
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_71716507
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aza Compounds - chemistry
Aza Compounds - metabolism
Azapeptidomimetics
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Medical sciences
Pharmacology. Drug treatments
Phenylalanine - chemistry
Phenylalanine - metabolism
Prodrug
Protein Binding
Serine Proteinase Inhibitors - chemical synthesis
Serine Proteinase Inhibitors - metabolism
Thrombin - antagonists & inhibitors
Thrombin - metabolism
Thrombin inhibitors
title Thrombin inhibitors built on an azaphenylalanine scaffold
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T15%3A20%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thrombin%20inhibitors%20built%20on%20an%20azaphenylalanine%20scaffold&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Zega,%20Anamarija&rft.date=2004-03-22&rft.volume=14&rft.issue=6&rft.spage=1563&rft.epage=1567&rft.pages=1563-1567&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2003.12.083&rft_dat=%3Cproquest_cross%3E71716507%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71716507&rft_id=info:pmid/15006404&rft_els_id=S0960894X04000095&rfr_iscdi=true